Portal de Periódicos da CAPES

Monoclonal Antibodies for Reproductive Health: Part I. Preventing Sexual Transmission of Disease and Pregnancy With Topically Applied Antibodies

1994; Wiley; Volume: 32; Issue: 2 Linguagem: Inglês

10.1111/j.1600-0897.1994.tb01102.x

1600-0897

Richard A. Cone, Kevin J. Whaley,

Food Allergy and Anaphylaxis Research

American Journal of Reproductive ImmunologyVolume 32, Issue 2 p. 114-131 Monoclonal Antibodies for Reproductive Health: Part I. Preventing Sexual Transmission of Disease and Pregnancy With Topically Applied Antibodies Richard A. Cone, Corresponding Author Richard A. Cone Thomas C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, MarylandThomas C. Jenkins Department of Biophysics, Johns Hopkins University, 3400 N. Charles, Baltimore, MD 21218.Search for more papers by this authorKevin J. Whaley, Kevin J. Whaley Thomas C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this author Richard A. Cone, Corresponding Author Richard A. Cone Thomas C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, MarylandThomas C. Jenkins Department of Biophysics, Johns Hopkins University, 3400 N. Charles, Baltimore, MD 21218.Search for more papers by this authorKevin J. Whaley, Kevin J. Whaley Thomas C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this author First published: September 1994 https://doi.org/10.1111/j.1600-0897.1994.tb01102.xCitations: 25AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Cates W, Stone KM. Family planning: The responsibility to prevent both pregnancy and reproductive tract infections. In: A Germain, KK Holmes, P Piot, JN Wasserheit, eds. Reproductive Tract Infections: Global Impact and Priorities for Women's Reproductive Health. New York: Plenum Press, 1992: 93–129. 2 Wasserheit JN, Holmes KK. Reproductive tract infections: Challenges for international health policy, programs and research. In: A Germain, KK Holmes, P Piot, JN Wasserheit, eds. Reproductive Tract Infections: Global Impact and Priorities for Women's Reproductive Health. New York: Plenum Press, 1992: 7–33. 3 Harlap S, Kost K, Forrest JD. Preventing Pregnancy, Protecting Health: A New Look at Birth Control Choices in the United States. New York: The Alan Guttmacher Institute, 1992: 1–128. 4 Bergstrom S. Genital infections and reproductive health: Infertility and morbidity of mother and child in developing countries. Scand J Infect Dis. 1990; S69: 99–105. 5 Dicsfalusy E. Contraceptive prevalence, reproductive health and our common future. Contraception. 1991; 43: 201–227. 6 Djerassi C. The bitter pill. Science. 1989; 245: 356–361. 7 Mastroianni L, Donaldson PJ, Kane TT. Developing New Contraceptives: Obstacles and Opportunities. Washington DC: National Academy Press, 1990: 1–193. 8 Rosenberg MJ, Holmes KK, World Health Organization Working Group on Virucides. Virucides in prevention of HIV infection. Sex Trans Dis. 1993; 20: 41–44. 9 Elias CJ, Heise L. The Development of Microbicides: A New Method of HIV Prevention for Women. New York: The Population Council Program Division Working Papers, 1993;No. 6: 1–105. 10 Khanna J, van Look PFA, Griffin PD. Reproductive health: A key to a brighter future. Biennial report 1990–1991. Geneva: World Health Organization, 1992. 11 National Center for Health Statistics. Health people 2000 review. Health United States, 1992. Hyattsville, Maryland: Public Health Service, 1993. 12 Lande R. Controlling Sexually Transmitted Diseases. Popul Rep. (L). 1993; 9: 1–31. 13 World Bank. World Development Report 1993. New York: Oxford University Press, 1993: 1–329. 14 Silverstein AM. The history of immunology. In: WE Paul, ed. Fundamental Immunology, Second Edition. New York: Raven Press, 1989: 21–38. 15 H Young, A McMillan, eds. Immunological Diagnosis of Sexually Transmitted Diseases. New York: Marcel Dekker Inc., 1988: 1–530. 16 Miller CJ, McGhee JR, Gardner MB. Biology of disease. Mucosal immunity, HIV transmission and AIDS. Lab Invest. 1992; 68: 129–145. 17 McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine. 1992; 10: 75–88. 18 Alexander NJ, Fulgham DL, Goldberg E. Contraceptive vaccine development: Secretory immune response in mice and monkeys. Vac Res. 1992; 1: 331–346. 19 Saltzman WM. Antibodies for treating and preventing disease: The potential role of polymeric controlled release. Crit Rev Ther Drug Carrier Syst. 1993; 10: 111–142. 20 Elder MG, Lawson JP, Elstein M, Nuttall ID. The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort. Contraception. 1991; 43: 129–137. 21 Radomsky ML, Whaley KJ, Cone RA, Saltzman WM. Controlled vaginal delivery of antibodies in the mouse. Biol Reprod. 1992; 47: 133–140. 22 Rogers B, Maczulak A. Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing. US Patent #5,069,896. 23 Ma JK-C, Smith R, Lehner T. Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans. Infect Immun. 1987; 55: 1274–1278. 24 Lenaerts V, Gurny R. Bioadhesive Drug Delivery Systems. Boca Raton, Florida: CRC Press, 1990: 1–231. 25 Ahnen DJ, Brown WR, Kloppel TM. Secretory component: The receptor that mediates external secretion of polymeric immunoglobulins. Receptors. 1986; 3: 1–52. 26 Hornick CL, Karush F. Antibody affinity-III: The role of multivalency. Immunochem. 1972; 9: 325–340. 27 Raff HV, Bradley C, Brady W, Donaldson K, Lipsich L, Maloney G, Shuford W, Walls M, Ward P, Wolff E, Harris LJ. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1. J Inject Dis. 1991; 163: 346–354. 28 Isojima S, Kameda K, Tsuji Y, Shigeta M, Ikeda, Y, Koyama K. Establishment and characterization of a human hybridoma secreting monoclonal antibody with high titers of sperm immobilizing and agglutinating activities against human seminal plasma. J Reprod Immunol. 1987; 10: 67–78. 29 Moore EW. Physiology of intestinal water and electrolyte absorption. American Gastroenterological Society, Baltimore: Milner-Fenwick, 1976. 30 Fischer GW, Siber GR. Human hyperimmune globulins for bacterial infections in high-risk children. In: SJ Cryz, ed. Vaccines and Immunotherapy. New York: Pergamon Press, 1991: 426–434. 31 Larrick JW. Human monoclonal antibodies for the prevention and treatment of infectious diseases. In: SJ Cryz, ed. Vaccines and Immunotherapy. New York: Pergamon Press, 1991: 453–463. 32 Kurpisz M. Development of human-human antisperm monoclonal antibodies. In: NJ Alexander, D Griffin, JM Spieler, GMH Waites, eds. Gamete Interaction. Prospects for Immunocontraception. New York: Wiley-Liss, 1990: 377–400. 33 Borrebaeck CAK Antibody Engineering. A Practical Guide. New York: WH Freeman and Co., 1992: 1–180. 34 Ebert KM, Selgrath JP, DiTullio P, Denman J, Smith TE, Memon MA, Schindler JE, Monastersky GM, Vitale JA, Gordon K. Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: Generation of transgenic goats and analysis of expression. Bio/Technology. 1991; 9: 835–838. 35 Hiatt A, Caffertey R, Bowdish K. Production of antibodies in transgenic plants. Nature. 1989; 342: 76–78. 36 Ogra PL, Fishaut M. Human breast milk. In: JS Remington, JO Kelin, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W.B. Saunders Co., 1990: 68–88. 37 Stephan W, Dichtelmuller H, Lissner R. Antibodies from colostrum in oral immunotherapy. J Clin Chem Clin Biochem. 1990; 28: 19–23. 38 Brussow H, Hilpert H, Walther I, Sidoti J, Mietens C, Bachmann P. Bovine milk for passive immunity to infantile rotavirus gastroenteritis. J Clin Microbiol. 1987; 25: 982–986. 39 Davidson GP, Daniels E, Nunan H, Moore AG, Whyte PBD, Franklin K, McCloud PI, Moore DJ. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet. 1989; ii: 709–712. 40 Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO. Treatment with bovine hyperimmune colostrum of cryposporidial diarrhea in AIDS patients. AIDS. 1990; 4: 581–584. 41 Hiatt A, Pinney R. “Plantibodies”: Expression of monoclonal antibodies in plants. In: CAK Borrebaeck, ed. Antibody Engineering. A Practical Guide. New York: WH Freeman and Co., 1992: 159–176. 42 Hiatt AC. Production of monoclonal antibody in plants. Washington D.C., Biotech USA Conference Proceedings, 1990: 107–111. 43 Tackett CO, Losonsky G, Link H, Hoang Y, Guesry P, Hilpert H, Levine MM. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Eschericia coli. N Engl J Med. 1988; 318: 1240–1243. 44 Eibl MM, Wolf HM, Furnkranz H, Rosenkranz A. Prophylaxis of necrotizing enterocolitis by oral IgA-IgG: Review of a clinical study in low birth weight infants and discussion of the pathogenic role of infection. J Clin Immunol. 1990; 10: 72S–79S. 45 Friberg J. Sperm-agglutinating antibodies and immunoglobulins G and A in stored human seminal fluid. Acta Obstet Gynecol Scand (Suppl.). 1974; 36: 59–63. 46 Tjokronegoro A, Sirisinha S. Degradation of immunoglobulins by secretions of human reproductive tracts. J Reprod Fertil. 1974; 38: 221–224. 47 Burke DS. Human HIV vaccine trials: Does antibody-dependent enhancement pose a genuine risk. Perspect Biol Med. 1992; 35: 511–530. 48 Robinson WE, Montefiori DC, Mitchell WM, Prince AM, Alter HJ, Dreesman GR, Eichberg JW. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1 infected and passively immunized chimpanzees. Proc Natl Acad Sci USA. 1989; 86: 4710–4714. 49 Witkin and Chaudhry A. Relationship between circulating antisperm antibodies in women and autoantibodies on the ejaculated sperm of their partners. Am J Obstet Gynecol. 1989; 161: 900–903. 50 Witkin S. Production of interferon gamma by lymphocytes exposed to antibody-coated spermatozoa: A mechanism for sperm antibody production in females. Fertil Steril. 1988; 50: 498–502. 51 Beck LR, Boots LR, Steven VC. Absorption of antibodies from the baboon vagina. Biol Reprod. 1975; 13: 10–16. 52 Isojima S, Ashitaka T. Absorption of sperm antigen from the vagina in guinea pigs. Am J Obstet Gynecol. 1964; 88: 433–438. 53 Okada H. Vaginal route of peptide and protein drug delivery. In: Peptide and Protein Drug Delivery. New York: Markel Dekker Publishers, 1991: 633–666. 54 Franek J, Libich J, Kubin V. Mechanisms of antibacterial immunity of mucous membranes. Folia Microbiol. 1984; 29: 375–384. 55 Dimmock NJ. Multiple mechanisms of neutralization of animal viruses. TIBS. 1987; 12: 70–75. 56 Baltz JM, Cone RA. The strength of non-covalent biological bonds and adhesions by multiple independent bonds. Theor Biol. 1990; 142: 163–178. 57 Baltz JM, Katz DF, Cone RA. Mechanics of sperm-egg interaction at the zona pellucida. Biophys J. 1988; 54: 643–654. 58 Tse S-K, Chadee K. The interaction between intestinal mucus glycoproteins and enteric infections. Parasit Today. 1991; 7: 162–172. 59 Kremer J, Jager S. The sperm-cervical mucus contact test: A preliminary report. Fertil Steril. 1976; 27: 335–340. 60 Jager S, Kremer J, Kuiken J, Mulder I. The significance of the Fe part of antispermatozoal antibodies for the shaking phenomenon in the sperm-cervical mucus contact test. Fertil Steril. 1981; 36: 792–797. 61 Kremer J, Jager S. Sperm-cervical mucus interaction, in particular in the presence of antispermatozoa antibodies. Hum Reprod. 1988; 3: 69–73. 62 Bronson RA, Cooper GW, Rosenfeld DL, Gilbert JV, Plaut AG. The effect of an IgA1 protease on immunoglobulins bound to the sperm surface and sperm cervical mucus penetrating ability. Fertil Steril. 1987; 47: 985–991. 63 Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. A three-tiered view of the role of IgA in mucosal defense. Immunol Today. 1993; 14: 430–435. 64 Cruz JR, Gil L, Cano F, Caceres P, Pareja G. Breast milk anti-Escherichia coli heat-labile toxin IgA antibodies protect against toxin-induced infantile diarrhea. Acta Paediatr Scand. 1988; 77: 658–662. 65 Tacket CO, Binion SB, Bostwick E, Losonsky G, Roy MJ, Edelman R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg. 1992; 47: 276–283. 66 Prince GA, Hemming VG, Horswood RL, Baron PA, Chanock RM. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J Virol. 1987; 61: 1851–1854. 67 Tamura S-i, Funato H, Hirabayashi Y, Kikuta K, Suzuki Y, Nagamine T, Aizawa C, Nakagawa M, Kurata T. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine. 1990; 8: 479–485. 68 Tamura S-i, Funato H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur J Immunol. 1991; 21: 1337–1344. 69 Renegar KB, Small PA. Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol. 1991; 145: 1972–1978. 70 Mazanec MB, Nedrud JG, Lamm ME. Immunoglobulin A monoclonal antibodies protect against Sendai virus. J Virol. 1987; 61: 2624–2626. 71 Mazanec MB, Lamm ME, Lyn D, Portner A, Nedrud JG. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res. 1992; 23: 1–12. 72 Bessen D, Fischetti VA. Passive acquired mucosal immunity to group A streptococi by secretory immunoglobulin. Am J Exp Med. 1988; 167: 1945–1950. 73 Ramise F, Szatanik M, Binder P, Alonso J-M. Passive local immunotherapy of experimental staphylococcal pneumonia with human intravenous immunoglobulin. J Infect Dis. 1993; 168: 1030–1035. 74 Klager AJ, Buchi ER, Osusky R, Burek-Kozlowska A, Morell A. Topical immunoglobulins for epithelial herpes simplex keratitis. Ophthalmologica. 1993; 207: 78–81. 75 Menge AC. Effects of isoimmunization and isoantisera against seminal antigens on fertility process in female rabbits. Biol Reprod. 1971; 4: 137–144. 76 Menge AC, Lieberman ME. Antifertility effects of immunoglobulins from uterine fluids of semen-immunized rabbits. Biol Reprod. 1974; 10: 422–428. 77 Dunbar BS. Antibodies to zona pellucida antigens and their role in fertility. In: TG Wegmann, TJ Gill, eds. Immunology of Reproduction. New York: Oxford University Press, 1983: 505–534. 78 Shaha C, Suri A, Talwar GP. Identification of sperm antigens that regulate fertility. Int J Androl. 1988; 11: 479–491. 79 Goldberg E, Lerum J. Pregnancy suppression by an antiserum to the sperm specific lactate dyhydrogenase. Science. 1972; 176: 686. 80 Vanage GR, Garde SV, Sheth AR, Gopalkrishnan K. Passive immunization against prostatic “inhibin” peptide as a male contraceptive. Int J Androl. 1992; 15: 114–126. 81 Naz RK, Saxe JM, Menge AC. Inhibition of fertility in rabbits by monoclonal antibodies against sperm. Biol Reprod. 1983; 28: 249–254. 82 East IJ, Mattison DR, Dean J. Monoclonal antibodies to the major protein of the murine zona pellucida: Effects on fertilization and early development. Dev Biol. 1984; 104: 49–56. 83 Saling PM, Waibel R. Mouse sperm antigens that participate in fertilization. III. Passive immunization with a single monoclonal antisperm antibody inhibits pregnancy and fertilization in vivo. Biol Reprod. 1985; 33: 537–544. 84 Castle PE, Whaley KJ, Moench TR, Hildreth JE, Saltzman WM, Radomsky ML, Hoen TE, Cone RA. Monoclonal IgM antibodies against rabbit sperm for vaginal contraception. J Androl. 1991; 12: Suppl.27. 85 Castle P, Whaley KJ, Moench TR, Hoen TE, Cone RA. Agglutination of rabbit sperm by a potent monoclonal antibody for vaginal contraception. Biol Reprod. 1993; 48: S181. 86 Centers for Disease Control. Postexposure prophylaxis of hepatitis B. MMWR 1984; 33: 285–290. 87 Rank RG, Batteiger BE. Protective role of serum antibody in immunity to chlamydia genital infection. Infect Immunol. 1989; 57: 299–301. 88 Baker MB, Larson CL, Ushijima RN, Anderson FD. Resistance of female mice to vaginal infection induced by Herpesvirus hominis type 2: Effects of immunization with mycobacterium bovis, intravenous injection of specific hervesvirus hominis type 2 antiserum and a combination of these procedures. Infect Immunol. 1974; 10: 1230–1234. 89 Azadegan AA, Schell RF, LeFrock JL. Immune serum confers protection against syphilitic infection on hamsters. Infect Immunol. 1983; 42: 42–47. 90 Titus RG, Weiser RS. Experimental syphilis in the rabbit: Passive transfer of immunity with immunoglobulin G from immune serum. J Infect Dis. 1979; 140: 904–913. 91 Neely AN, Holder IA. Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice. Antimicrol. Agents Chemother. 1992; 36: 643–646. 92 Gunnel B, Putkonen P, Thorstensson R, Norrby E. Protection against HIV-2 and SIVsm infection in passively immunized cynomolgus monkeys. AIDS Res. Hum Retro. 1992; 8: 896. 93 Emini EA, Schleif WA, Nunberg JH, Conley AJ, Eda Y, Tokiyoshi S, Putney SD, Matsushita S, Cobb KE, Jett CM, Eichberg JW, Murthy KK. Prevention of HIV-1 infection in chimpanzees by gp 120 V3 domain-specific monoclonal antibody. Nature. 1992; 355: 728–730. 94 Safrit JT, Fung MSC, Andrew CA, Braun DG, Sun WNC, Chang TW, Koup RA. hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp 120. AIDS 1993; 7: 15–21. 95 Atherton SS. Protection from retinal necrosis by passive transfer of monoclonal antibody specific for herpes simplex virus glycoprotein D. Curr Eye Res. 1992; 11: 45–52. 96 Eis-Hubinger AM, Schmidt DS, Schneweis. Anti-glycopro-tein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J Gen Virol. 1993; 74: 379–385. 97 Balachandran N, Bacchetti, Rawls WE. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immunol. 1982; 37: 1132–1137. 98 Whaley KJ, Zeitlin L, Barratt RA, Hoen TE, Cone RA. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J Infect Dis. 1994; 169:. 99 Brooks CF, Lammel CJ, Petersen BH, Stites DP. Human seminal plasma inhibition of antibody complement-mediated killing and opsonization of Neisseria gonorrhoeae and other gram-negative organisms. J Clin Invest. 1981; 67: 1523–1531. 100 James K, Harvey J, Bradbury AW, Hargreave TB, Cullen RT. The effect of seminal plasma on macrophage function—A possible contributory factor in sexually transmitted disease. AIDS Res. 1983; 1: 45–57. 101 Alexander NJ, Anderson DJ. Immunology of semen. Fertil Steril. 1987; 47: 192–205. 102 Witkin SS. Mechanisms of active suppression of the immune response to spermatozoa. Am J Reprod Immunol. Microbiol. 1988; 17: 61–64. 103 Adams LE, Donovan-Brand R, Friedman-Kien A, Ramahl KE, Hess EV. Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromes. Clin Immunol Immunopathol. 1988; 46: 442–449. 104 Rooney IA, Davies A, Morgan BP. Membrane attack complex (MAC)-mediated damage to spermatozoa: Protection of the cells by the presence on their membranes of MAC inhibitory proteins. Immunology. 75: 499–506. 105 Goodenough UW. Deception by pathogens. Am Sci. 1991; 79: 344–355. 106 Gooding LR. Virus proteins that counteract host immune defenses. Cell. 1992; 71: 5–7. 107 Mims CA. The Pathogenesis of Infectious Disease. London: Academic Press, 1988: 1–342. 108 Arthur LO, Bess JW, Sowder RC, Beneveniste RE, Mann DL, Chermann J-C, Henderson LE. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 1992; 258: 1935–1938. 109 McKeating JA, Griffiths PD, Grundy JE. Cytomegalovirus in urine specimens has host B2-microglobulin bound to the viral envelope: A mechanism of evading the host immune response. J Gen Virol. 1987; 68: 785–792. 110 Smith H, Cole JA, Parsons NJ. The sialylation of gonococcal lipopolysaccharide by host factors: A major impact on pathogenicity. FEMS Microbiol Lett. 1992; 100: 287–292. 111 Mandrell RE. Further antigenic similarities of Neisseria gonorrhoeae lipooligosaccharides and human glycosphingolipids. Infect Immunol. 1992; 60: 3017–3020. 112 Schulze IT, Manger ID. Viral glycoprotein heterogeneity—Enhancement of functional diversity. Glycoconjugate J. 1992; 9: 63–66. 113 Banks TA, Rouse BT. Herpesviruses—Immune escape artists? Clin Infect Dis. 1992; 14: 933–941. 114 Baughn RE. Role of fibronectin in the pathogenesis of syphilis. Rev Infect Dis. 1987; 9: S372–S385. 115 Cohen MS, Sparling PF. Mucosal infection with Neisseria gonorrhoeae. Bacterial adaptation and mucosal defenses. J Clin Invest. 1992; 89: 1699–1705. 116 Isojima S, Tsuji Y, Kameda K, Shigeta M, Hakomori S-I. Coating antigens of human seminal plasma involved in fertilization. In: NJ Alexander, D Griffin, JM Spieler, GMH Waites, eds. Gamete Interatiction. Prospects for Immunocontraception. New York: Wiley-Liss, 1990: 155–174. 117 Jones R. Membrane remodeling during sperm maturation in the epididymis. Oxf Rev Reprod. 1989; 11: 285–337. 118 Voglmay JK, Sawyer RF. Surface transformation of ram spermatozoa in uterine, oviduct and cauda epididymal fluids in vitro. J Reprod Fertil. 1986; 78: 315–325. 119 Zagury D, Bernard J, Leibowitch J, Safai B, Groopman JE, Feldman M, Sarnagharan MG, Gallo RC. HTLV-III in cells cultured from semen of two patients with AIDS. Science. 1984; 226: 449–451. 120 Levy JA. The transmission of AIDS: The case of the infected cell. JAMA 1988; 259: 3037–3038. 121 Levy JA. The transmission of HIV and factors influencing progression to AIDS. Am J Med. 1993; 95: 86–100. 122 Anderson D, Yunis EJ. “Trojan horse” leukocytes in AIDS. N Engl J Med. 1983; 309: 984–985. 123 Bourinbaiar AS, Phillips DM. Transmission of human immunodeficiency virus from monocytes to epithelia. J AIDS. 1991; 4: 56–63. 124 Phillips DM, Bourinbaiar AS. Mechanisms of HIV spread from lymphocytes to epithelia. Virology. 1992; 186: 261–273. 125 Moench TR, Whaley KJ, Mandrell TD, Bishop BD, Witt CJ, Cone RA. The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: Nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. AIDS. 1993; 7: 797–802. 126 Toth A. The role of spermatozoa in the development of pelvic inflammatory disease in the woman. Adv Contracept. 1987; 3: 97–102. 127 Gnarpe H, Friberg J. T mycoplasmas on spermatozoa and infertility. Nature. 1973; 245: 97–98. 128 Hill AC. Mycoplasma spermatophilum, a new species isolated from human spermatozoa and cervix. Int J System Bacter. 1991; 42: 229–233. 129 Huang E-S, Davis MG, Baskar JF, Huong S-M. Molecular epidemiology and oncogenicity of human cytomegalovirus. In: CC Harris, ed. Biochemical and Molecular Biology of Cancer. UCLA Symposium on Molecular Biopsy. New York: Alan R. Liss, 1986; 40: 323–344. 130 Lusso P, Mainati MS, Garzino A, Crowley RW, Long EO, Gallo RC. Infection of natural killer cells by human herpesvirus 6. Nature. 1993; 362: 458–462. 131 Anderson D. Mechanisms of HIV-1 transmission via semen. J NIH Res. 1992; 4: 104–108. 132 Baccetti B, Benedetto A, Burrini AG, Collodel G, Elia C, Piomboni P, Renieri T, Sensini C, Zaccarelli M. HIV particles detected in spermatozoa of patients with AIDS. J Submicrosc Cytol Pathol. 1991; 23: 339–345. 133 Scofield VL. Sperm as vectors and cofactors for HIV-1 transmission. J NIH Res. 1992; 4: 105–111. 134 Wilson CB, Tsai C, Remington JS. Failure to trigger the oxidative metabolic burst by normal macrophages. Possible mechanism for survival of intracellular pathogens. J Ex Med. 1980; 151: 328–346. 135 D'Cruz OJ, Wang L-L, Haas GG. Phagocytosis of immunoglobulin G and C3-bound human sperm by human polymorphonuclear leukocytes is not associated with the release of oxidative radicals. Biol Reprod. 1992; 46: 721–732. 136 Bronson RA. Immunology. In: MM Seibel, ed. Infertility: A Comprehensive Text. Norwalk, CT: Appleton & Lange, 1990: 217–234. 137 Isojima S. Human sperm antigens corresponding to sperm-immobilizing antibodies in the sera of women with infertility of unknown cause: Personal review of our recent studies. Hum Reprod. 1989; 4: 605–612. 138 Primakoff P, Lathrop W, Bronwon R. Identification of human sperm surface glycoproteins recognized by auto-antisera from immune infertile men, women and vasectomized men. Biol Reprod. 1990; 42: 929–942. 139 Cunningham DS, Fulgham DL, Rayl DL, Hansens KA, Alexander NJ. Antisperm antibodies to sperm surface antigens in women with genital tract infection. Am J Obstet Gynecol. 1991; 164: 791–796. 140 Goldberg E. Lactate dehydrogenase C4 as an immunocontraceptive model. In: NJ Alexander, D Griffin, JM Spieler, GMH Waites, eds. Gamete Interaction: Prospects for Immunocontraception. New York: Wiley-Liss, 1990: 63–73. 141 Primakoff P, Lathrop W, Woolman L, Cowan A, Myles D. Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20. Nature. 1988; 335: 543–546. 142 Herr JC, Wright RM, John E, Klotz K, Momyk M, Foster J, Flickinger CJ. Monoclonal antibody MHS-10 and its cognate intra-acrosomal antigen SP-10. In: NJ Alexander, D Griffin, JM Spieler, GMH Waites, eds. Gamete Interaction. Prospects for Immunocontraception. New York: Wiley-Liss, 1990: 13–36. 143 Anderson DJ, Johnson PM, Alexander NJ, Jones WR, Griffin D. Monoclonal antibodies to human trophoblast and sperm antigens: Report of two WHO-sponsored workshops, June 30, 1986, Toronto, Canada. J Reprod Immunol. 1987; 10: 231–257. 144 Isojima S. Sperm and seminal plasma antigens relevant to contraceptive vaccine development. Curr Opin Immunol. 1990; 2: 752–756. 145 Tsuji Y, Clausen H, Nudelman E, Kaizu T, Hakomori S-I, Isojima S. Human sperm carbohydrate antigens defined by an antisperm human monoclonal antibody derived from an infertile woman bearing antisperm antibodies in her serum. J Exp Med. 1988; 168: 343–356. 146 Kurpisz M, Clark GF, Mahony M, Anderson TL, Alexander NJ. Mouse monoclonal antibodies against human sperm: Evidence for immunodominant glycosylate antigenic sites. Clin Exp Immunol. 1989; 78: 250–255. 147 Mettler L, Paul S, Bauklow V, Feller AC. Monoclonal sperm antibodies: Their potential for investigation of sperms as target of immunological contraception. Am J Reprod Immunol. 1984; 5: 125–128. 148 Menge AC, Shoultz GK, Kelsey DE, Rutherford P, Lee C-YG. Characterization of monoclonal antibodies against human sperm antigens by immunoassays including sperm function assays and epitope evaluation. Am J Reprod Immunol. 1987; 13: 108–114. 149 Lehner T, Hussain L, Wilson L, Wilson J, Chapman M. Mucosal transmission of HIV. Nature. 1991; 353: 709. 150 Tlaskalova-Hogenova H, Mandel L, Stepankova R, Bartova J, Barot R, LeClerc M, Kovaru F, Trebichavsky I. Autoimmunity: From Physiology to pathology. Natural antibodies, mucosal immunity and development of B cell repertoire. Folia Biol (Praha). 1992; 38: 202–215. 151 Avrameas S. Natural autoantibodies: From “horror autotoxicuas” to “gnothi seauton.” Immunol Today. 1991; 12: 154–159. 152 Avrameas S, Guilbert B, Dighiero G. Natural autoantibodies against tubulin, actin, myoglobulin, thyroglobulin, fetuin, albumin and transferrin are present in normal sera and monoclonal immunoglobulins from multiple myeloma and Waldenstrom's macroglobulinemia may express similar antibody specificities. Ann Inst Pasteur Immunol. 1981; 132C: 231–236. 153 Bohn J, Josimovic-Alasevic O, Settmacher U, Kiessig ST, Lukowsky A, Volk H-D, Diamantstein T, von Baehr R, Jahn S. Human monoclonal IgM antibodies from foetal B-cell hybridomas directed against a surface antigen on human tumour cells. Res Immunol. 1992; 143: 879–891. 154 Christiane Y, Aghayan M, Emonard H, Lallemand A, Mahieu PH, Foidart JM. Galactose alpha 1–3 galactose and anti-alpha galactose antibody in normal and pathological pregnancies. Placenta. 1992; 13: 475–487. 155 Kermer J, Jager S. The significance of antisperm antibodies for sperm-cervical mucus interaction. Hum Reprod. 1992; 7: 781–784. 156 Hjort T. Studies with clinically defined sera from fertile and infertile patients: An overview. In: NJ Alexander, D Griffin, JM Spieler, GMH Waites, eds. Gamete Interaction. Prospects for Immunocontraception. New York: Wiley-Liss, 1990: 333–344. 157 Ada GL. Immunosafety aspects of fertility control vaccines. In: NJ Alexander, D Griffin, JM Spieler, GMH Waites, eds. Gamete Interaction. Prospects for Immuncontraception. New York: Wiley-Liss, 1990: 565–578. 158 Tung K. Model of autoimmunity to spermatozoa and testis. In: TG Wegmann, TJ Gill, eds. Immunology of Reproduction. New York: Oxford University Press, 1983: 389–423. 159 Aitken RJ, Paterson M, Koothan Thillai P. Contraceptive vaccines. Br Med Bull. 1993; 49: 88–99. 160 Ben K, Hamilton MS, Alexander NJ. Vasectomy-induced autoimmunity: Monoclonal antibodies affect sperm function and in vitro fertilization. J Reprod Immunol. 1988; 13: 73–84. 161 Arthur LO, Bess JW, Sowder RC, Beneveniste RE, Mann DL, Chermann J-C, Henderson LE. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 1992; 258: 1935–1938. 162 Fellous M, Colle A, Tonnelle C. The expression of human beta2-microglobulin on human spermatozoa. Eur J Immunol. 1987; 6: 21–24. 163 Warren JT, Dolatshahi M. Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: Vaccines associate with active and passive immunie protection from live virus challenge. J Med Primatol. 1992; 21: 139–186. 164 Stott EJ. Anti-cell antibody in macaques. Nature. 1991; 353: 393. 165 Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg MI, Bolognesi DP. The ability of certain SIV vaccines to provoke reactions against normal cells. Science. 1992; 255: 292–293. 166 Di Cesare S, Poccia F, Mastino A, Colizzi V. Surface expressed heat-shock proteins by stressed or human immunodeficiency virus (HIV)-infected lymphoid cells represent the target for antibody-dependent cellular cytotoxicity. Immunology. 1992; 76: 341–343. 167 Sabin AB. HIV vaccination dilemma. Nature. 1993; 362: 212. 168 Pearce-Pratt R, Phillips DM. Studies of adhesion of lymphocytic cells: Implications for sexual transmission of human immunodeficiency virus. Biol Reprod. 1993; 48: 431–445. 169 Shearer GM, Clerici M, Dalgleish A. Alloimmunization as an AIDS vaccine? Science 1993; 262: 161. Citing Literature Volume32, Issue2September 1994Pages 114-131 ReferencesRelatedInformation